SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-16-004457
Filing Date
2016-03-30
Accepted
2016-03-29 18:59:57
Documents
80
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mirn-20151231x10k.htm 10-K 2711167
2 EX-10.13 mirn-20151231ex1013fedd7.htm EX-10.13 288499
3 EX-23.1 mirn-20151231ex231cfed84.htm EX-23.1 4129
4 EX-31.1 mirn-20151231ex311b6a37d.htm EX-31.1 18601
5 EX-31.2 mirn-20151231ex31288b79b.htm EX-31.2 20041
6 EX-32.1 mirn-20151231ex321e47b0b.htm EX-32.1 12761
7 GRAPHIC mirn20151231x10k001.jpg GRAPHIC 18769
8 GRAPHIC mirn20151231x10k002.jpg GRAPHIC 36140
9 GRAPHIC mirn20151231x10k003.jpg GRAPHIC 57915
10 GRAPHIC mirn20151231x10k004.jpg GRAPHIC 102318
11 GRAPHIC mirn20151231x10k005.jpg GRAPHIC 64711
  Complete submission text file 0001558370-16-004457.txt   8518108

Data Files

Seq Description Document Type Size
12 EX-101.INS mirn-20151231.xml EX-101.INS 1523096
13 EX-101.SCH mirn-20151231.xsd EX-101.SCH 48159
14 EX-101.CAL mirn-20151231_cal.xml EX-101.CAL 40687
15 EX-101.DEF mirn-20151231_def.xml EX-101.DEF 181774
16 EX-101.LAB mirn-20151231_lab.xml EX-101.LAB 426842
17 EX-101.PRE mirn-20151231_pre.xml EX-101.PRE 334858
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744 512-681-5252
Mirna Therapeutics, Inc. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37566 | Film No.: 161536676
SIC: 2834 Pharmaceutical Preparations